ici 164384 has been researched along with thymidine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gelly, C; Pasqualini, JR | 1 |
| Alibadi, T; Cathapermal, S; Lavigne, MC; Leong-Son, M; Ramwell, PW | 1 |
2 other study(ies) available for ici 164384 and thymidine
| Article | Year |
|---|---|
Biological response of the anti-estrogen ICI 164,384 in human hormone-dependent and hormone-independent mammary cancer cell lines.
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Division; DNA, Neoplasm; Estradiol; Estrogen Antagonists; Female; Humans; Neoplasms, Hormone-Dependent; Polyunsaturated Alkamides; Receptors, Progesterone; Thymidine; Tumor Cells, Cultured | 1990 |
Stereoisomer-specific inhibition of superoxide anion-induced rat aortic smooth-muscle cell proliferation by 17beta-estradiol is estrogen receptor dependent.
Topics: Animals; Aorta, Thoracic; Cell Division; Cells, Cultured; Dose-Response Relationship, Drug; Estradiol; Estrogen Antagonists; Male; Muscle, Smooth, Vascular; Polyunsaturated Alkamides; Progesterone; Rats; Rats, Sprague-Dawley; Receptors, Estrogen; Stereoisomerism; Superoxides; Testosterone; Thymidine; Xanthine Oxidase | 1998 |